Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme
about
Breastfeeding and Opiate Substitution Therapy: Starting to Understand Infant Feeding ChoicesABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-Ethyl-5-methyl-3,3-diphenylpyroline (EMDDevelopment and validation of a method for the determination of buprenorphine and norbuprenorphine in breast milk by gas chromatography-mass spectrometry.ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.Pharmacokinetics of methadone.Methadone exposure during lactation.Excretion of antihypertensive medication into human breast milk: a systematic review.Studying drugs in human milk: time to unify the approach.Estimated infant exposure to enantiomer-specific methadone levels in breastmilkMethadone maintenance and lactation: a review of the literature and current management guidelines.Methadone reincarnated: novel clinical applications with related concerns.Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosingDrug use and breastfeeding.Pregnancy and injecting drug use.Management of the newborn infant affected by maternal opiates and other drugs of dependency.Methadone maintenance and long-term lactation.Concentrations of methadone in breast milk and plasma in the immediate perinatal period.Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.Maternal and neonatal hair and breast milk in the assessment of perinatal exposure to drugs of abuse.Breastfeeding Considerations for Mothers of Infants with Neonatal Abstinence Syndrome.Forensic Investigation of Methadone Concentrations in Deceased Breastfed Infants.Is maternal opioid use hazardous to breast-fed infants?The profile of substance-using pregnant mothers and their newborns at a regional rural hospital in New South Wales.
P2860
Q26739956-A09E4927-46BD-4B82-9BC9-87CD1BF7C3D4Q28081894-907C77C6-CB92-45EA-8CED-7C573F6EAE3FQ33437532-311F3725-3A29-40B2-B37E-AF01888A1DF3Q33948169-6E9C8C58-198B-49F4-B4C3-8866E122154FQ34341036-F42D2B12-47E9-445E-BB47-57A6487B32EFQ34487284-90B61231-8E9C-4072-ABD5-10666F68B285Q34601781-9C3B1A36-B254-4074-8742-EAC9DDB6D030Q34666718-03CC2F67-7C62-4F1A-B94C-701D3769977DQ35007992-6D9789A4-B772-469F-A9FC-CEEB42148CD3Q35586272-5DF415B5-FC11-49D6-B3FD-C3A305DE39E7Q35671539-58AAE2EF-29A8-48CD-949B-A2035F2EF927Q35751695-D0A7764C-15C6-45EC-97E3-5AC9C0B69C73Q36054231-1E336803-F089-4FE4-96D5-7FDDA5F84A91Q36191050-A2864DD1-E805-4F66-A2F0-61D0AFF0582CQ36700709-E5A74FE7-6273-47F4-97F8-48AC51B8B3CBQ36700962-A9234382-A201-4FEA-AC5E-3C88F6C17591Q37210284-A861871D-EF2F-4531-80B1-D0E0538A701CQ37281595-FF00E717-C128-4C13-A7EC-ABA36C87D74EQ37761296-450DF344-F10F-410F-8D67-1D7977FE9D19Q38516618-6027D60F-3605-4952-98C3-D196BAFCBC1DQ39295315-B3A381D5-318A-4E31-B43B-46037480C0B2Q40380339-5FDF9DAF-C9E5-49F3-BFB9-003FA33CE050Q43063862-83BBAD18-E62A-4AA4-9CFF-D144A40F061DQ43852257-02BF3DC6-F486-4897-9344-530C3CA3B159
P2860
Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Methadone distribution and exc ...... ethadone maintenance programme
@ast
Methadone distribution and exc ...... ethadone maintenance programme
@en
type
label
Methadone distribution and exc ...... ethadone maintenance programme
@ast
Methadone distribution and exc ...... ethadone maintenance programme
@en
prefLabel
Methadone distribution and exc ...... ethadone maintenance programme
@ast
Methadone distribution and exc ...... ethadone maintenance programme
@en
P2093
P1476
Methadone distribution and exc ...... ethadone maintenance programme
@en
P2093
Hackett LP
Kristensen JH
Wojnar-Horton RE
P304
P356
10.1046/J.1365-2125.1997.T01-1-00624.X
P407
P577
1997-12-01T00:00:00Z